News

In the case of temporary orders and temporary production cycles, a high investment in the acquisition of a permanent automation solution usually does not pay off, or only partially.
News
27. Apr 2022
In our series "Strong Characters" we introduce them: The people behind the scenes at ESSERT Robotics. In this interview, Matthias Weber (33), automation technician.
Interview
27. Apr 2022
Söhner Kunststofftechnik GmbH and system integrator ESSERT Robotics enter into a strategic partnership. In the automation of manual work activities, one of the core processes is the provision and processing of different materials.
News
27. Apr 2022
In our series "Strong Characters" we introduce them: The heroes and heroines at ESSERT Robotics who give their best day after day. In this interview, Martin Rockenberger (30), responsible for logistics management.
Interview
27. Apr 2022
Classic special solutions for the automation of work processes have a long industrial history and are still established today. Their main advantage, with which these sometimes very large mechanical systems score points - speed and high output - is at...
News
27. Apr 2022
ESSERT GmbH opens a branch office in North Rhine-Westphalia. Under the management of Moritz Latzel, the new sales & service office in the Cologne area will start its work from 01.05.2020 and in the future will increasingly serve customers in the...
News
4. Apr 2022
DIN EN ISO 9001:20015 is the most widely used and most important national and international standard in quality management. It serves, as a basis for the continuous improvement process, primarily the fulfillment of customer requirements and our efforts to always meet...
News
29. Mar 2022
In our series "Strong Characters" we introduce them: The heroines and heroes at ESSERT who give their best day after day. In this interview, Kathrin Unger (36), Management Assistant.
Interview
17. Mar 2022
The trend towards smaller batch sizes and shorter product life cycles is not stopping in the pharmaceutical industry. Although there are still the large high-runner products, more and more specialized drugs for smaller target groups are also being offered on...
News
1. Jan 2022